// App-Quantinova.ai

17913 : Inhibition of CETP by Dalcetrapib Results in a Modest Increase in Cholesterol Efflux Capacity Associated With an Increase in Large HDL Particles, but Does Not Impact Carotid Intima-Media Thickness in a dal-PLAQUE-2 Substudy

Researchers

Presenter

  • Marie Boule

Principal Investigators

  • Sonia Alem

  • Mathieu R. Brodeur

  • Daniel Charpentier

  • Olivier Gingras

  • Malorie Chabot-Blanchet

  • Marie-Claude Guertin

  • Guillaume Lettre

  • Eric Rheaume

  • Jean-Claude Tardif

Medical Centers

  • Montreal Heart Institute, Montreal, Quebec, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Stable coronary artery disease

  • Coronary Artery Disease

Biomarkers

  • Cholesterol

  • Cyclic adenosine monophosphate

Drug/Treatment

  • Dalcetrapib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved